What criteria for pharmaceuticals reimbursement? : An empirical analysis of the evaluation of "medical service rendered" by reimbursable drugs in France
Year of publication: |
2003
|
---|---|
Authors: | Le Pen, Claude ; Priol, G. ; Lilliu, H. |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 4.2003, 1, p. 30-36
|
Subject: | Arzneimittel | Pharmaceuticals | Gesundheitsfinanzierung | Health care financing | Gesundheitskosten | Health care costs | Frankreich | France |
Extent: | graph. Darst |
---|---|
Type of publication: | Article |
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Notes: | In: The European Journal of Health Economics |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Pricing and incentives in publicly subsidized health care markets : the case of Medicare Part D
Decarolis, Francesco, (2012)
-
Erstattungsbetragsverhandlungen bei innovativen Arzneimitteln aus Sicht des GKV-Spitzenverbandes
Stackelberg, Johann-Magnus von, (2015)
-
Bredesen, Geir, (2003)
- More ...
-
Le Pen, Claude, (2008)
-
"Patient" ou "personne malade"? : Les nouvelles figures du consommateur de soins
Le Pen, Claude, (2009)
-
Un modèle de comportament bureaucratique
Le Pen, Claude, (1982)
- More ...